Hepatitis B Virus Biology
Open accessThe DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Abstract
SUMMARY: Hepadnaviruses (hepatitis B viruses) cause transient and chronic infections of the liver. Transient infections run a course of several months, and chronic infections are often lifelong. Chronic infections can lead to liver failure with cirrhosis and hepatocellular carcinoma. The replication strategy of these viruses has been described in great detail, but virus-host interactions leading to acute and chronic disease are still poorly understood. Studies on how the virus evades the immune response to cause prolonged transient infections with high-titer viremia and lifelong infections with an ongoing inflammation of the liver are still at an early stage, and the role of the virus in liver cancer is still elusive. The state of knowledge in this very active field is therefore reviewed with an emphasis on past accomplishments as well as goals for the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F., & Weiss, R. A. (1984) · Nature · doi:10.1038/312763a0 · Cited by 3,533
DNA Replication in Eukaryotic Cells
Bell, S. P., & Dutta, A. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135425 · Cited by 2,060
Estimates of the worldwide incidence of 25 major cancers in 1990
Parkin, Pisani, P., & Ferlay, J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990315)80:6<827::aid-ijc6>3.0.co;2-p · Cited by 2,037
Viral Hepatitis and Liver Disease
Vyas, G. N., Dienstag, J. L., & Hoofnagle, J. H. (1985) · Medical Entomology and Zoology · Cited by 1,860
Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis
Hayward, W. S., Neel, B. G., & Astrin, S. M. (1981) · Nature · doi:10.1038/290475a0 · Cited by 1,567
Mutational hot spot in the p53 gene in human hepatocellular carcinomas
Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., & Harris, C. C. (1991) · Nature · doi:10.1038/350427a0 · Cited by 1,534
Summers, J., & Mason, W. S. (1982) · Cell · doi:10.1016/0092-8674(82)90157-x · Cited by 1,443
Self-citationSelective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
Bressac, B., Kew, M., Wands, J., & Ozturk, M. (1991) · Nature · doi:10.1038/350429a0 · Cited by 1,432
Hepatitis B virus.The major etiology of hepatocellular carcinoma
Beasley, R. P. (1988) · Cancer · doi:10.1002/1097-0142(19880515)61:10<1942::aid-cncr2820611003>3.0.co;2-j · Cited by 1,280
Cited by
Lok, A. S. F., & McMahon, B. J. (2007) · Hepatology · doi:10.1002/hep.21513 · Cited by 3,087
Genomic analysis of the host response to hepatitis C virus infection
Su, A. I., Pezacki, J. P., Wodicka, L., Brideau, A. D., Supekova, L., Thimme, R., Wieland, S., Bukh, J., Purcell, R. H., Schultz, P. G., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202608199 · Cited by 1,161
Domingo, E., Sheldon, J., & Perales, C. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05023-11 · Cited by 1,009
Yuen, M.-F., Chen, D.-S., Dusheiko, G. M., Janssen, H. L. A., Lau, D. T. Y., Locarnini, S. A., Peters, M. G., & Lai, C.-L. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.35 · Cited by 814
IMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS
Guidotti, L. G., & Chisari, F. V. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100230 · Cited by 811
Ni, Y., Lempp, F. A., Mehrle, S., Nkongolo, S., Kaufman, C., Fälth, M., Stindt, J., Königer, C., Nassal, M., Kubitz, R., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.024 · Cited by 781
Why do viruses cause cancer? Highlights of the first century of human tumour virology
Moore, P. S., & Chang, Y. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2961 · Cited by 745
Lok, A. S. F., & McMahon, B. J. (2001) · Hepatology · doi:10.1053/jhep.2001.29401 · Cited by 709
Hepatitis B Virus Resistance to Nucleos(t)ide Analogues
Zoulim, F., & Locarnini, S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.063 · Cited by 706
Genomic analysis of the host response to hepatitis B virus infection
Wieland, S., Thimme, R., Purcell, R. H., & Chisari, F. V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401771101 · Cited by 652
Loomba, R., & Liang, T. J. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.02.009 · Cited by 594
Lipid nanoparticles for nucleic acid delivery: Current perspectives
Samaridou, E., Heyes, J., & Lutwyche, P. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.002 · Cited by 583
Bréchot, C., Thiers, V., Kremsdorf, D., Nalpas, B., Pol, S., & Paterlini-Bréchot, P. (2001) · Hepatology · doi:10.1053/jhep.2001.25172 · Cited by 560
Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor
Decorsière, A., Mueller, H., van Breugel, P. C., Abdul, F., Gerossier, L., Beran, R. K., Livingston, C. M., Niu, C., Fletcher, S. P., Hantz, O., et al. (2016) · Nature · doi:10.1038/nature17170 · Cited by 551
The changing pattern of epidemiology in hepatocellular carcinoma
Nordenstedt, H., White, D. L., & El-Serag, H. B. (2010) · Digestive and Liver Disease · doi:10.1016/s1590-8658(10)60507-5 · Cited by 535
Exosomes mediate the cell-to-cell transmission of IFN-α-induced antiviral activity
Li, J., Liu, K., Liu, Y., Xu, Y., Zhang, F., Yang, H., Liu, J., Pan, T., Chen, J., Wu, M., et al. (2013) · Nature Immunology · doi:10.1038/ni.2647 · Cited by 509
Molecular viral oncology of hepatocellular carcinoma
Block, T. M., Mehta, A. S., Fimmel, C. J., & Jordan, R. (2003) · Oncogene · doi:10.1038/sj.onc.1206557 · Cited by 495
Beck, J. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i1.48 · Cited by 494
Spatial heterogeneity in the mammalian liver
Ben-Moshe, S., & Itzkovitz, S. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0134-x · Cited by 485
Pollicino, T., Belloni, L., Raffa, G., Pediconi, N., Squadrito, G., Raimondo, G., & Levrero, M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.001 · Cited by 472
Shouval, D. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00152-1 · Cited by 470
Stealth and Cunning: Hepatitis B and Hepatitis C Viruses
Wieland, S. F., & Chisari, F. V. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9369-9380.2005 · Cited by 457
Schulze, A., Gripon, P., & Urban, S. (2007) · Hepatology · doi:10.1002/hep.21896 · Cited by 445
Pathogenesis of hepatitis B virus infection
Chisari, F. V., Isogawa, M., & Wieland., S. F. (2010) · Pathologie Biologie · doi:10.1016/j.patbio.2009.11.001 · Cited by 414
Viruses associated with human cancer
McLaughlin-Drubin, M. E., & Munger, K. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.12.005 · Cited by 406
Vaccine instability in the cold chain: Mechanisms, analysis and formulation strategies
Kumru, O. S., Joshi, S. B., Smith, D. E., Middaugh, C. R., Prusik, T., & Volkin, D. B. (2014) · Biologicals · doi:10.1016/j.biologicals.2014.05.007 · Cited by 404
A Positive-Strand RNA Virus Replication Complex Parallels Form and Function of Retrovirus Capsids
Schwartz, M., Chen, J., Janda, M., Sullivan, M., den Boon, J., & Ahlquist, P. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00474-4 · Cited by 397
Petersen, J., Dandri, M., Mier, W., Lütgehetmann, M., Volz, T., von Weizsäcker, F., Haberkorn, U., Fischer, L., Pollok, J.-M., Erbes, B., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1389 · Cited by 397
The immune response during hepatitis B virus infection
Bertoletti, A., & Gehring, A. J. (2006) · Journal of General Virology · doi:10.1099/vir.0.81920-0 · Cited by 385
Weak Protein−Protein Interactions Are Sufficient To Drive Assembly of Hepatitis B Virus Capsids
Ceres, P., & Zlotnick, A. (2002) · Biochemistry · doi:10.1021/bi0261645 · Cited by 377
Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes
Urban, S., Bartenschlager, R., Kubitz, R., & Zoulim, F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.04.030 · Cited by 361
Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment
Bissig, K.-D., Wieland, S. F., Tran, P., Isogawa, M., Le, T. T., Chisari, F. V., & Verma, I. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40094 · Cited by 356
Gripon, P., Cannie, I., & Urban, S. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1613-1622.2005 · Cited by 347
Guo, H., Jiang, D., Zhou, T., Cuconati, A., Block, T. M., & Guo, J.-T. (2007) · Journal of Virology · doi:10.1128/jvi.01123-07 · Cited by 335
Murakami, Y., Saigo, K., Takashima, H., Minami, M., Okanoue, T., Bréchot, C., & Paterlini-Bréchot, P. (2005) · Gut · doi:10.1136/gut.2004.054452 · Cited by 331
Lee, M.-H., Yang, H.-I., Liu, J., Batrla-Utermann, R., Jen, C.-L., Iloeje, U. H., Lu, S.-N., You, S.-L., Wang, L.-Y., & Chen, C.-J. (2013) · Hepatology · doi:10.1002/hep.26385 · Cited by 322
The role of cytokines in hepatocellular carcinoma
Budhu, A., & Wang, X. W. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0506297 · Cited by 319
Kim, S.-J., Khan, M., Quan, J., Till, A., Subramani, S., & Siddiqui, A. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003722 · Cited by 317
Small interfering RNA Inhibits Hepatitis B virus replication in mice
Giladi, H., Ketzinel-Gilad, M., Rivkin, L., Felig, Y., Nussbaum, O., & Galun, E. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00244-2 · Cited by 306
Hepatitis B‐related hepatocellular carcinoma: epidemiological characteristics and disease burden
Nguyen, V. T. T., Law, M. G., & Dore, G. J. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01117.x · Cited by 302
Targeting Hepatitis B Virus With CRISPR/Cas9
Seeger, C., & Sohn, J. A. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.68 · Cited by 294
Self-citationSubversion of Cellular Autophagy Machinery by Hepatitis B Virus for Viral Envelopment
Li, J., Liu, Y., Wang, Z., Liu, K., Wang, Y., Liu, J., Ding, H., & Yuan, Z. (2011) · Journal of Virology · doi:10.1128/jvi.02627-10 · Cited by 293
Molecular functions and biological roles of hepatitis B virus x protein
Tang, H., Oishi, N., Kaneko, S., & Murakami, S. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00299.x · Cited by 282
Nuclear import of hepatitis B virus capsids and release of the viral genome
Rabe, B., Vlachou, A., Panté, N., Helenius, A., & Kann, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1730940100 · Cited by 280
Hepatitis B virus PreS/S gene variants: Pathobiology and clinical implications
Pollicino, T., Cacciola, I., Saffioti, F., & Raimondo, G. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.041 · Cited by 277
A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly
Stray, S. J., Bourne, C. R., Punna, S., Lewis, W. G., Finn, M. G., & Zlotnick, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409732102 · Cited by 267
Yan, H., Peng, B., Liu, Y., Xu, G., He, W., Ren, B., Jing, Z., Sui, J., & Li, W. (2014) · Journal of Virology · doi:10.1128/jvi.03478-13 · Cited by 263
Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma
D'souza, S., Lau, K. C., Coffin, C. S., & Patel, T. R. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i38.5759 · Cited by 257
Nkongolo, S., Ni, Y., Lempp, F. A., Kaufman, C., Lindner, T., Esser-Nobis, K., Lohmann, V., Mier, W., Mehrle, S., & Urban, S. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.11.022 · Cited by 255
Bonvin, M., Achermann, F., Greeve, I., Stroka, D., Keogh, A., Inderbitzin, D., Candinas, D., Sommer, P., Wain‐Hobson, S., Vartanian, J., et al. (2006) · Hepatology · doi:10.1002/hep.21187 · Cited by 253
Kakimi, K., Lane, T. E., Wieland, S., Asensio, V. C., Campbell, I. L., Chisari, F. V., & Guidotti, L. G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.12.1755 · Cited by 234
Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview
Marra, M., Sordelli, I. M., Lombardi, A., Lamberti, M., Tarantino, L., Giudice, A., Stiuso, P., Abbruzzese, A., Sperlongano, R., Accardo, M., et al. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-171 · Cited by 230
“HBV virus HBV belongs to a family of closely related DNA viruses, called Hepadnaviridae [30].”
BackgroundRivino, L., Le Bert, N., Gill, U. S., Kunasegaran, K., Cheng, Y., Tan, D. Z. M., Becht, E., Hansi, N. K., Foster, G. R., Su, T.-H., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci92812 · Cited by 208
“HBV is a DNA virus that infects hepatocytes and establishes a mini-chromosome (cccDNA) that acts as a template for HBV replication and antigenic production (2).”
BackgroundAssociations Between Hepatitis B Virus Infection and Risk of All Cancer Types
Song, C., Lv, J., Liu, Y., Chen, J. G., Ge, Z., Zhu, J., Dai, J., Du, L.-B., Yu, C., Guo, Y., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.5718 · Cited by 192
A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook
Kramvis, A., Chang, K.-M., Dandri, M., Farci, P., Glebe, D., Hu, J., Janssen, H. L. A., Lau, D. T. Y., Penicaud, C., Pollicino, T., et al. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00649-z · Cited by 185
BAY 41-4109 has multiple effects on Hepatitis B virus capsid assembly
Stray, S. J., & Zlotnick, A. (2006) · Journal of Molecular Recognition · doi:10.1002/jmr.801 · Cited by 182
“…particles consist of a 3.5 kb partially single-stranded circular genome, and a single copy of the viral reverse transcriptase encapsidated in an icosahedral protein capsid composed of 120 HBV capsid protein (Cp) dimers, host chaperones, and kinases may also be incorporated (Seeger and Mason, 2000).”
InfluentialSulfamoylbenzamide Derivatives Inhibit the Assembly of Hepatitis B Virus Nucleocapsids
Campagna, M. R., Liu, F., Mao, R., Mills, C., Cai, D., Guo, F., Zhao, X., Ye, H., Cuconati, A., Guo, H., et al. (2013) · Journal of Virology · doi:10.1128/jvi.00582-13 · Cited by 180
Drug Targets and Molecular Mechanisms of Drug Resistance in Chronic Hepatitis B
Ghany, M., & Liang, T. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.039 · Cited by 172
Epidemiology and prevention of hepatitis B virus infection
Kwon, S. Y., & Lee, C. H. (2011) · The Korean Journal of Hepatology · doi:10.3350/kjhep.2011.17.2.87 · Cited by 171
“The virus has a partially double-stranded DNA with core antigen surrounded by a shell containing surface antigen (HBsAg).(3) HBV contains numerous antigenic components, including HBsAg, HBcAg, and hepatitis B e antigen (HBeAg).”
BackgroundLauber, C., Seitz, S., Mattei, S., Suh, A., Beck, J., Herstein, J., Börold, J., Salzburger, W., Kaderali, L., Briggs, J. A. G., et al. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.07.019 · Cited by 168
“2 kb circular genomes are reverse-transcribed from an RNA intermediate by the viral P protein (Seeger and Mason, 2000; Beck and Nassal, 2007).”
InfluentialSpecific mutations of hepatitis B virus in plasma predict liver cancer development
Kuang, S.-Y., Jackson, P. E., Wang, J.-B., Lu, P.-X., Muñoz, A., Qian, G.-S., Kensler, T. W., & Groopman, J. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308232100 · Cited by 165
Bacteria-Human Somatic Cell Lateral Gene Transfer Is Enriched in Cancer Samples
Riley, D. R., Sieber, K. B., Robinson, K. M., White, J. R., Ganesan, A., Nourbakhsh, S., & Dunning Hotopp, J. C. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003107 · Cited by 163
“Almost all cancers associated with Hepatitis B virus (HBV) have the virus integrated into tumor cells [34].”
BackgroundInfection and Cancer: The Case of Hepatitis B
Chan, S. L., Wong, V. W. S., Qin, S., & Chan, H. L. Y. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.5724 · Cited by 162
Pre-Clinical Evaluation of a Novel Nanoemulsion-Based Hepatitis B Mucosal Vaccine
Makidon, P. E., Bielinska, A. U., Nigavekar, S. S., Janczak, K. W., Knowlton, J., Scott, A. J., Mank, N., Cao, Z., Rathinavelu, S., Beer, M. R., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002954 · Cited by 159
“Hepatitis B surface antigen (HBsAg) is a major structural protein of HBV and is a protective immunogen in experimental animals and in humans [8,9,10].”
BackgroundDelaney, W. E., Edwards, R., Colledge, D., Shaw, T., Furman, P., Painter, G., & Locarnini, S. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.3057-3060.2002 · Cited by 158
“Chronic hepatitis B virus (HBV) infection, a major cause of hepatocellular carcinoma and liver cirrhosis, affects about 5% of the world’s human population (19, 24 ).”
BackgroundChen, Y., Wei, H., Sun, R., Dong, Z., Zhang, J., & Tian, Z. (2007) · Hepatology · doi:10.1002/hep.21872 · Cited by 130
Ratcliff, J., & Simmonds, P. (2021) · Virology · doi:10.1016/j.virol.2020.12.018 · Cited by 108
Donkers, J. M., Zehnder, B., van Westen, G. J. P., Kwakkenbos, M. J., IJzerman, A. P., Oude Elferink, R. P. J., Beuers, U., Urban, S., & van de Graaf, S. F. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-15338-0 · Cited by 90
Natural history of chronic hepatitis B virus infection.
Busch, K., & Thimme, R. (2015) · Medical Microbiology and Immunology · doi:10.1007/s00430-014-0369-7 · Cited by 68
Liver regeneration after injury: Mechanisms, cellular interactions and therapeutic innovations
Liu, Q., Wang, S., Fu, J., Chen, Y., Xu, J., Wei, W., Song, H., Zhao, X., & Wang, H. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1812 · Cited by 49
Digital PCR: From early developments to its future application in clinics
Trouchet, A., Gines, G., Benhaim, L., & Taly, V. (2025) · Lab on a Chip · doi:10.1039/d5lc00055f · Cited by 43
Microfluidic platform for hepatitis B viral replication study
Sodunke, T. R., Bouchard, M. J., & Noh, H. (. (2008) · Biomedical Microdevices · doi:10.1007/s10544-007-9148-1 · Cited by 38
Design of efficacious somatic cell genome editing strategies for recessive and polygenic diseases
Carlson-Stevermer, J., Das, A., Abdeen, A. A., Fiflis, D., Grindel, B. I., Saxena, S., Akcan, T., Alam, T., Kletzien, H., Kohlenberg, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20065-8 · Cited by 32
GalNac-siRNA conjugate delivery technology promotes the treatment of typical chronic liver diseases
Qin, Z.-X., Zuo, L., Zeng, Z., Ma, R., Xie, W., Zhu, X., & Zhou, X. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2466767 · Cited by 32
“( 8) DNA plus strand synthesis follows [128,130].”
Metadata
- Authors
- Seeger, C., & Mason, W. S.
- Venue
- Microbiology and Molecular Biology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2000-03
- Volume
- 64
- Issue
- 1
- Pages
- 51-68
- ISSN
- 1092-2172 (ISSN-L)
- 1098-5557
- OpenAlex
- W2107057287
- Cited by
- 1,451
- References
- 150
- FWCI
- 6.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.